FROG printed Q2 earnings on August 6 and jumped 12% on the week to $89.52, triggering the broadest single-day wave of target raises the stock has seen this cycle — and the question now is whether the Street was simply too conservative heading into the print.
The analyst response left little ambiguity about how the results landed. Every firm that moved on August 7 raised its price target, with no downgrades or holds added to the pile. JPMorgan lifted to $115 from $100 while keeping its Overweight rating — a meaningful signal from a bellwether that the Q2 beat was not already priced in. TD Cowen and Benchmark both moved to $120. Needham made the boldest adjustment, going from $80 to $115. The one hold-out in tone is Piper Sandler, which raised its target to $90 from $65 while staying at Neutral — essentially acknowledging the beat without committing to the bull case. The consensus mean now sits at $108.95, roughly 22% above the current price, up sharply from the $94.38 implied in the pre-earnings preview. That gap between where the stock trades and where the Street now places fair value is the sharpest it has been in some time.
Short interest heading into the print was already on a long unwind, and the post-earnings pop has extended that trend. Shorts had been cutting positions steadily since mid-July, when FROG carried nearly 11.2 million shares short. By August 6 that had fallen to 8.25 million shares, or roughly 7% of the free float — still elevated enough to matter, but down nearly 5% on the week. The borrow market remains entirely relaxed. Cost to borrow is just 0.50%, barely above its 30-day average, and availability has widened dramatically — now running above 1,130% — meaning shares to borrow are abundant relative to existing short interest. That combination, modest SI and loose borrow conditions, suggests the week's 12% move was driven by genuine buyers, not short covering. The ORTEX short score has drifted down to 45.5, consistent with a stock where positioning pressure is easing rather than building.
The one signal that stands in slight contrast to the bullish consensus is options. The put/call ratio jumped to 0.31 on August 7, more than two standard deviations above its 20-day average of 0.21 — the highest defensive skew in at least a month. That single-day spike may simply reflect traders hedging fresh long positions after a sharp single-week move, rather than genuine bearish conviction. Prior to the earnings date, the PCR had been running at multi-month lows near 0.16-0.17, confirming that the market was leaning call-heavy into results. The post-print shift in PCR is worth watching but does not yet look like a structural turn.
From an ownership angle, the institutional picture has some interesting texture. BlackRock added a significant 5.6 million shares in July, lifting its stake to 6% of outstanding — a meaningful accumulation from a passive anchor that often reflects index re-weighting or active ETF flow. On the insider side, co-founder and CTO Yoav Landman sold approximately $3.9 million of stock on July 17, shortly before the Q2 report. The sales came at prices between $84 and $89 — below where the stock now trades — and carry low significance scores. They do not look like distress signals, but the timing is worth noting given the subsequent move.
Peer performance adds some useful context to the week. GTLB also rallied strongly, up nearly 13% on the week, while RBRK surged 24% — both pointing to a broader software/security sector re-rating rather than FROG-specific outperformance alone. DDOG, by contrast, fell 13% on the week, suggesting the earnings-driven gains are unevenly distributed across the cohort. The next FROG earnings event is not scheduled until November 6, leaving the next three months as a period where the stock's performance will hinge on whether the raised analyst targets and AI infrastructure narrative hold up against broader macro conditions and competitive developments in the DevSecOps market.
See the live data behind this article on ORTEX.
Open FROG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
